Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 11, Number 8—August 2005


Cost-Benefit of Stockpiling Drugs for Influenza Pandemic

Ran D. Balicer*†Comments to Author , Michael Huerta*, Nadav Davidovitch*†, and Itamar Grotto*†
Author affiliations: *Ministry of Health, Jerusalem, Israel; †Ben-Gurion University of the Negev, Be'er-Sheva, Israel

Main Article

Table A2

Cost and benefit parameters included in the model

Variable Point estimate (US$) Reference
Average daily wage* 71.6 14
Cost of hospital day* 317.8 14
Cost of physician visit*† 45.3 17
Antiviral (NAI) drug costs‡
5-day therapeutic course 8.9 Roche, pers. comm.
7-day prophylactic course 6.2 Roche, pers. comm

*Converted from original prices in NIS (new Israeli shekels) at the rate of US$1 = 4.50 NIS.
†Physician costs include prescription drugs and diagnostic tests.
‡NAI, neuraminidase inhibitors. Based on manufacturer's quoted price for oseltamivir.

Main Article